Here, we demonstrate the promoting effects of CBX2 on cancer cell proliferation, resistance to cisplatin and IR, and cancer stemness in vitro and in vivo, unveiling the possibility of CBX2 as a biomarker of resistance to DNA-damaging treatment and a therapeutic target in cervical cancer, which warrants further investigations. Here, CBX2 is linked to cervical cancer.